PuSH - Publikationsserver des Helmholtz Zentrums München

Dabbah-Krancher, G.* ; Ruchinskas, A.* ; Kallarakal, M.A.* ; Lee, K.P.* ; Bauman, B.M.* ; Epstein, B.* ; Yin, H. ; Krappmann, D. ; Schaefer, B.C.* ; Snow, A.L.*

A20 intrinsically influences human effector T-cell survival and function by regulating both NF-κB and JNK signaling.

Eur. J. Immunol.:e2451245 (2024)
DOI PMC
A20 is a dual-function ubiquitin-editing enzyme that maintains immune homeostasis by restraining inflammation. Although A20 serves a similar negative feedback function for T-cell receptor (TCR) signaling, the molecular mechanisms utilized and their ultimate impact on human T-cell function remain unclear. TCR engagement triggers the assembly of the CARD11-BCL10-MALT1 (CBM) protein complex, a signaling platform that governs the activation of downstream transcription factors including NF-κB and c-Jun/AP-1. Utilizing WT and A20 knockout Jurkat T cells, we found that A20 is required to negatively regulate NF-κB and JNK. Utilizing a novel set of A20 mutants in NF-κB and AP-1-driven reporter systems, we discovered the ZnF7 domain is crucial for negative regulatory capacity, while deubiquitinase activity is dispensable. Successful inactivation of A20 in human primary effector T cells congruently conferred sustained NF-κB and JNK signaling, including enhanced upregulation of activation markers, and increased secretion of several cytokines including IL-9. Finally, loss of A20 in primary human T cells resulted in decreased sensitivity to restimulation-induced cell death and increased sensitivity to cytokine withdrawal-induced death. These findings demonstrate the importance of A20 in maintaining T-cell homeostasis via negative regulation of both NF-κB and JNK signaling.
Impact Factor
Scopus SNIP
Altmetric
4.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Apoptosis ; Cellular Immunology ; Cytokines ; Signal Transduction ; T Cells; Transcription Factor Pu.1; Linear Polyubiquitin; Gene-expression; Enzyme A20; Tnfaip3; Binding; Activation; Inhibition; Mutations; Haploinsufficiency
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 0014-2980
e-ISSN 1521-4141
Quellenangaben Band: , Heft: , Seiten: , Artikelnummer: e2451245 Supplement: ,
Verlag Wiley
Verlagsort Hoboken
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Signaling and Translation (SAT)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-509800-001
G-509800-002
Förderungen NIH Blood Bank - National Institutes of Health
National Institutes of Health
Scopus ID 85205357891
PubMed ID 39359035
Erfassungsdatum 2024-10-31